Skip to Content


As a leader in our SEC practice, I primarily assist public companies with SEC filings, including initial public offerings (IPOs), secondary public offerings (SPOs), reverse mergers, and complex financing transactions. In addition, in my work with biotechnology and life sciences organizations, I specialize in advising executives, so they can stay on the cutting edge of the bioscience industry regulations, trends, and financial best practices. I also have expertise in debt and equity financing transactions.
View More of Rebecca's Experience
I’m a Colorado native with no interest in living anywhere else. My family likes being active and enjoys all the state has to offer — from the mountains, beautiful seasons, skiing, and just being together.

You might also like…

FASB ASC 606 recent updates: What’s changed and what hasn’t
Lisa Plonka
Article February 11, 2021 3 min read
OMB 2020 Compliance Supplement Addendum: Higher education considerations
Katie Thornton
Article February 5, 2021 2 min read
Financial Institutions Advisor: Insights for 2021 and beyond
White Paper February 5, 2021 10 min read